
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206
Showing 1-25 of 206 citing articles:
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 310
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 310
Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems
Cinzia Cimino, Oriana Maria Maurel, Teresa Musumeci, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 327-327
Open Access | Times Cited: 198
Cinzia Cimino, Oriana Maria Maurel, Teresa Musumeci, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 327-327
Open Access | Times Cited: 198
Epidemiology of anxiety disorders: global burden and sociodemographic associations
Syed Fahad Javaid, Ibrahim Jawad Hashim, Muhammad Jawad Hashim, et al.
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 148
Syed Fahad Javaid, Ibrahim Jawad Hashim, Muhammad Jawad Hashim, et al.
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 148
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation
Vaishali Chugh, K. Vijaya Krishna, Abhay Pandit
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17080-17123
Open Access | Times Cited: 117
Vaishali Chugh, K. Vijaya Krishna, Abhay Pandit
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17080-17123
Open Access | Times Cited: 117
The Neuropsychology of Anxiety
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
Neil McNaughton, Jeffrey A. Gray
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 73
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders
Borwin Bandelow, Christer Allgulander, David S. Baldwin, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 2, pp. 79-117
Closed Access | Times Cited: 72
Borwin Bandelow, Christer Allgulander, David S. Baldwin, et al.
The World Journal of Biological Psychiatry (2022) Vol. 24, Iss. 2, pp. 79-117
Closed Access | Times Cited: 72
The nature and neurobiology of fear and anxiety: State of the science and opportunities for accelerating discovery
Shannon E. Grogans, Eliza Bliss‐Moreau, Kristin A. Buss, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105237-105237
Closed Access | Times Cited: 45
Shannon E. Grogans, Eliza Bliss‐Moreau, Kristin A. Buss, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105237-105237
Closed Access | Times Cited: 45
Drug development in psychiatry: 50 years of failure and how to resuscitate it
David Nutt
The Lancet Psychiatry (2025)
Closed Access | Times Cited: 2
David Nutt
The Lancet Psychiatry (2025)
Closed Access | Times Cited: 2
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Anupam Sah, Nicolas Singewald
Pharmacology & Therapeutics (2025), pp. 108825-108825
Closed Access | Times Cited: 2
Anupam Sah, Nicolas Singewald
Pharmacology & Therapeutics (2025), pp. 108825-108825
Closed Access | Times Cited: 2
Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders
Kerry J. Ressler
American Journal of Psychiatry (2020) Vol. 177, Iss. 3, pp. 214-222
Open Access | Times Cited: 82
Kerry J. Ressler
American Journal of Psychiatry (2020) Vol. 177, Iss. 3, pp. 214-222
Open Access | Times Cited: 82
Human fear conditioning: From neuroscience to the clinic
Miquel À. Fullana, Joseph E. Dunsmoor, Koen Schruers, et al.
Behaviour Research and Therapy (2019) Vol. 124, pp. 103528-103528
Open Access | Times Cited: 79
Miquel À. Fullana, Joseph E. Dunsmoor, Koen Schruers, et al.
Behaviour Research and Therapy (2019) Vol. 124, pp. 103528-103528
Open Access | Times Cited: 79
Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update
Maša Kenda, Nina Kočevar Glavač, Milan Nagy, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6021-6021
Open Access | Times Cited: 60
Maša Kenda, Nina Kočevar Glavač, Milan Nagy, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6021-6021
Open Access | Times Cited: 60
Lactobacillus rhamnosus GG colonization in early life regulates gut-brain axis and relieves anxiety-like behavior in adulthood
Bingqian Zhou, Ge Jin, Xiaoqi Pang, et al.
Pharmacological Research (2022) Vol. 177, pp. 106090-106090
Closed Access | Times Cited: 48
Bingqian Zhou, Ge Jin, Xiaoqi Pang, et al.
Pharmacological Research (2022) Vol. 177, pp. 106090-106090
Closed Access | Times Cited: 48
Melatonin as a Potential Approach to Anxiety Treatment
Kristina Repova, Tomáš Baka, Kristina Krajcirovicova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16187-16187
Open Access | Times Cited: 41
Kristina Repova, Tomáš Baka, Kristina Krajcirovicova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16187-16187
Open Access | Times Cited: 41
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 39
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 39
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity
Yingjie Du, Yunfeng Li, Xiangting Zhao, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 31
Yingjie Du, Yunfeng Li, Xiangting Zhao, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 31
Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents
Erika Plazas, Nicoletta Faraone
Biomedicines (2023) Vol. 11, Iss. 2, pp. 461-461
Open Access | Times Cited: 23
Erika Plazas, Nicoletta Faraone
Biomedicines (2023) Vol. 11, Iss. 2, pp. 461-461
Open Access | Times Cited: 23
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 113-123
Open Access | Times Cited: 13
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 113-123
Open Access | Times Cited: 13
Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline
Sinead Rooney, Anupam Sah, Michael S. Unger, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 54
Sinead Rooney, Anupam Sah, Michael S. Unger, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 54
Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice
Błażej D. Pędzich, Sarah Rubens, Mehdi Sekssaoui, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1304-1314
Open Access | Times Cited: 34
Błażej D. Pędzich, Sarah Rubens, Mehdi Sekssaoui, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1304-1314
Open Access | Times Cited: 34
Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article
Nazanin Hatami Bavarsad, Shokufeh Bagheri, Masoumeh Kourosh‐Arami, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18492-e18492
Open Access | Times Cited: 19
Nazanin Hatami Bavarsad, Shokufeh Bagheri, Masoumeh Kourosh‐Arami, et al.
Heliyon (2023) Vol. 9, Iss. 8, pp. e18492-e18492
Open Access | Times Cited: 19
Sex Differences in Stress Response: Classical Mechanisms and Beyond
Georgia E. Hodes, Debra A. Bangasser, Ioannis Sotiropoulos, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 475-494
Open Access | Times Cited: 19
Georgia E. Hodes, Debra A. Bangasser, Ioannis Sotiropoulos, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 475-494
Open Access | Times Cited: 19
Treatment of Anxiety Disorders
Soo‐Hee Choi, Murray Stein
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 7
Soo‐Hee Choi, Murray Stein
American Psychiatric Association Publishing eBooks (2024)
Closed Access | Times Cited: 7
Anxiety Disorders: Treatments, Models, and Circuitry Mechanisms
Li Ren, Yue Fan, Wenjian Wu, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176994-176994
Open Access | Times Cited: 6
Li Ren, Yue Fan, Wenjian Wu, et al.
European Journal of Pharmacology (2024) Vol. 983, pp. 176994-176994
Open Access | Times Cited: 6